Early spinal cord pseudoatrophy in interferon‐beta‐treated multiple sclerosis-Reference-Cited by-同舟云学术

Early spinal cord pseudoatrophy in interferon‐beta‐treated multiple sclerosis

Published:2022-11-17 Issue:2 Volume:30 Page:453-462
ISSN:1351-5101
Container-title:European Journal of Neurology
language:en
Short-container-title:Euro J of Neurology

Author:

Matusche Britta¹^ORCID,Litvin Ludmila¹,Schneider Ruth²,Bellenberg Barbara¹^ORCID,Mühlau Mark³,Pongratz Viola³,Berthele Achim³,Groppa Sergiu⁴,Muthuraman Muthuraman⁴,Zipp Frauke⁴,Paul Friedemann⁵,Wiendl Heinz⁶,Meuth Sven G.⁷,Sämann Philipp⁸,Weber Frank⁹,Linker Ralf A.¹⁰,Kümpfel Tania¹¹,Gold Ralf²,Lukas Carsten¹

Affiliation:

1. Institute for Neuroradiology, St Josef Hospital, Ruhr University Bochum Bochum Germany

2. Department of Neurology St Josef Hospital, Ruhr University Bochum Bochum Germany

3. Department of Neurology Klinikum Rechts der Isar, School of Medicine, Technical University of Munich Munich Germany

4. Department of Neurology, Focus Program Translational Neuroscience and Immunotherapy, Rhine‐Main Neuroscience Network University Medical Center of the Johannes Gutenberg University Mainz Mainz Germany

5. Experimental and Clinical Research Center, Max Delbrueck Center for Molecular Medicine Charité‐Universitätsmedizin Berlin Berlin Germany

6. Department of Neurology Institute of Translational Neurology, University of Münster Münster Germany

7. Department of Neurology, Medical Faculty Heinrich Heine University Düsseldorf Düsseldorf Germany

8. Max Planck Institute of Psychiatry Munich Germany

9. Neurological Clinic, Sana Clinic Cham Cham Germany

10. Department of Neurology University of Regensburg Regensburg Germany

11. Institute of Clinical Neuroimmunology, Biomedical Center and University Hospital, Ludwig Maximilian University of Munich Munich Germany

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ene.15620

Reference42 articles.

1. Evidence of early cortical atrophy in MS: Relevance to white matter changes and disability

2. Brain atrophy in clinically early relapsing–remitting multiple sclerosis

3. Brain atrophy in multiple sclerosis: mechanisms, clinical relevance and treatment options

4. Atrophy and structural variability of the upper cervical cord in early multiple sclerosis